Research Article
Risk Factors for Symptomatic Pericardial Effusions Posthematopoietic Stem Cell Transplant
Table 3
Pretransplant comparison of cardiac markers.
| | PCE subjects | Controls | N | Mean | N | Mean | P value |
| Number of days after BMT | 15 | 121 | | | | Duration of effusion (days) | 15 | 98 | | | | Hemoglobin (gm/dl) | 12 | 9.3 | 15 | 9.9 | 0.38 | Ejection fraction (%) | 15 | 65 | 15 | 66 | 0.44 | Shortening fraction (%) | 15 | 37 | 15 | 39 | 0.06 | LVIDd (cm; z-score) | 13 | 0.9 | 15 | 0.4 | 0.18 | MV E max vel (cm/sec) | 13 | 107.1 | 15 | 110.7 | 0.49 | MV E/A | 13 | 1.6 | 15 | 2.1 | 0.21 | Mitral E/TDI E′ (septal) | 12 | 8.6 | 12 | 8.2 | 0.72 | Mitral E/TDI E′ (lateral) | 12 | 7.2 | 12 | 7.4 | 0.80 | Apical 4 Ch LV peak avg | 9 | −18.07 | 14 | −18.8 | 0.65 |
|
|
t-test comparison, significant. LVIDd, left ventricle end diastolic diameter; MV, mitral valve. |